Clinical Trial Transparency Update!

A brief report on an assessment of the disclosure of results of company-sponsored trials associated with new  medicines approved in Europe in 2012!

The outcome of a study aimed to assess the timely disclosure of results of company-sponsored clinical trials related to all new medicines approved by the European Medicines Agency (EMA) during 2012 has been published in the journal Current Medical Research and Opinion.

The study concludes that the industry is now achieving disclosure in a timely manner more consistently than before. The overall disclosure rate at study end of 92% indicates that the improvement in transparency amongst company-sponsored trials has been maintained in the trials associated with new medicines approved in 2012. To read through the detail of this update please click here